Empirical Bioscience has been acquired by Fortis Life Sciences
The owner of Empirical Bioscience has sold the company to Fortis Life Sciences.
Empirical Bioscience is a leading developer and manufacturer of enzymes, proteins and reagents for molecular biology and life science applications. Empirical focuses on supplying premium, quality and custom-configured products to the life sciences industry for both research and commercial applications. The company has a comprehensive library of products that can be readily configured to customer specifications and offers technical support to assist with the development and launch of assays and products.
Fortis Life Sciences is a strategic platform providing capital, expertise and operational resources enabling the growth and success of founder-led life science tools companies.
One of Oaklins’ teams in the USA served as the financial advisor to Empirical Bioscience in its sale to Fortis Life Sciences.
Porozmawiaj z zespołem obsługi transakcji
Bradford A. Adams
Oaklins TM Capital
Michael S. Goldman
Oaklins TM Capital
Harrison P. Boeschenstein
Oaklins TM Capital
Powiązane transakcje
Dania Software has been acquired by Omnidocs
The owners of Dania Software A/S have sold the company to Omnidocs.
Więcej informacjiTop Systems teams up with Holland Capital to create the premier Dutch battery-based solutions provider
Holland Capital, a Netherlands-based private equity firm, has acquired a stake in Top Systems, a leading provider of complete battery-based power solutions, with a unique value-added services proposition.
Więcej informacjiSoler & Palau Ventilation has acquired subsidiaries of United Enertech Holdings
Soler & Palau Ventilation, Inc. (S&P) has acquired subsidiaries of United Enertech Holdings, LLC. (UEH). The subsidiaries included Air Conditioning Products, LLC; Air Performance, LLC; Metal Form Manufacturing, LLC; and United Enertech Corp.
Więcej informacji